Research Article
The Association of Serum Anti-Lysosomal-Associated Membrane Protein-2 Antibody with Vasculitis Combined with Hypertension
Table 2
Clinical features of patients with vasculitis combined with hypertension.
| | Clinical features | VAS-HTN (n = 51) | AAV (n = 20) | PAN (n = 24) | TA (n = 7) |
| | Headache, n (%) | 30 (58.8) | 9 (45.0) | 18 (75.0) | 3 (42.9) | | Constitutional symptoms, n (%) | 32 (62.7) | 13 (65.0) | 15 (62.5) | 4 (57.1) | | Nervous systems, n (%) | 4 (7.8) | 2 (10.0) | 1 (4.2) | 1 (14.3) | | Renal systems, n (%) | 31 (60.8) | 12 (60.0) | 16 (66.7) | 3 (42.9) | | Cutaneous, n (%) | 4 (7.8) | 0 (0) | 3 (12.5) | 1 (14.3) | | Arthritis/joint pain, n (%) | 2 (3.9) | 0 (0) | 2 (8.3) | 0 (0) | | Eye, n (%) | 15 (29.4) | 7 (35.0) | 7 (29.2) | 1 (14.3) | | Ear nose throat, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | | Pulmonary system, n (%) | 9 (17.6) | 9 (45.0) | 0 (0) | 0 (0) | | Alimentary system, n (%) | 6 (11.8) | 3 (15.0) | 2 (8.3) | 1 (14.3) | | Cardiovascular system, n (%) | 10 (19.6) | 5 (25.0) | 5 (20.8) | 0 (0) | | Active disease, n (%) | 35 (68.6) | 13 (65.0) | 19 (79.2) | 3 (42.9) | | BVAS | 11.35 ± 8.61 | 12.35 ± 10.82 | 11.21 ± 6.36 | 9.00 ± 9.07 |
|
|
Continuous variables are shown as mean ± standard deviation.
|
